.Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AA12_Tobramycin.Tobramycin .Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AA12_Tobramycin.Tobramycin| name: | Tobramycin |
| ATC code: | S01AA12 | route: | intravenous |
| n-compartments | 2 |
Tobramycin is an aminoglycoside antibiotic primarily used to treat serious bacterial infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa. It is commonly used in ophthalmic formulations and is approved for both systemic and topical use.
Pharmacokinetics in healthy adult volunteers after intravenous administration.
Sullins, AK, & Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatric drugs 15(2) 93–117. DOI:10.1007/s40272-013-0017-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23529866
Praet, A, et al., & Goutelle, S (2021). Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis. Antimicrobial agents and chemotherapy 65(10) e0073721–None. DOI:10.1128/AAC.00737-21 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34280011
Bloomfield, C, et al., & Hennig, S (2016). Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients. Antimicrobial agents and chemotherapy 60(6) 3407–3414. DOI:10.1128/AAC.02654-15 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27001806